乙型肝炎患者血清乙型肝炎病毒-DNA与常用血清标志物的相关性分析
Correlation between HBV-DNA and routine serum markers in patients with hepatitis B virus infection
-
摘要: 目的: 评估乙型肝炎(乙肝)患者血清乙肝病毒DNA(HBV-DNA)载量与血清免疫和生化标志物之间的关系。方法: 收集214例乙肝患者血清, 分别用荧光定量PCR法、化学发光法和速率法检测血清中的HBV-DNA、乙肝病毒表面抗原(HBsAg)、乙肝病毒e抗原(HBeAg)和丙氨酸氨基转移酶(ALT), 分析各标志物之间的关系。结果: 214例中, HBV-DNA阳性率为57.48%;HBeAg阳性率为28.04%。HBV-DNA载量与HBsAg和ALT水平均无相关关系(P>0.05), 但与HBeAg水平密切相关(P<0.01), HBV-DNA阳性组的HBeAg和ALT水平均明显高于HBV-DNA阴性组(P<0.01)。结论: HBV-DNA载量与HBeAg水平呈正相关关系, 与HBsAg和ALT水平无相关性, HBsAg水平作为HBV-DNA的替代方法仍需进一步验证。Abstract: Objective: To explore the correlation between hepatitis B virus(HBV)-DNA load and routine serum markers in patients with HBV infection.Methods: The serum HBV-DNA,hepatitis B virus surface antigen(HBsAg),hepatitis B virus e antigen(HBeAg) and alanine aminotransferase(ALT) in 214 patients with HBV infection were detected using TaqMan real time polymerase chain reaction,chemiluminescence and rate assay.The relationship between the markers were analyzed.Results: Among the 214 patients,the positive rates of HBV-DNA and HBeAg were 57.48% and 28.04%,respectively.The HBV-DNA load was not related to HBsAg and ALT(P>0.05),and was closely related to the HBeAg level(P<0.01).The levels of HBeAg and ALT in positive HBV-DNA group were significantly higher than those in negative HBV-DNA group(P<0.01).Conclusions: The HBV-DNA load is positive correlation with the HBeAg level,and is not correlation with HBsAg and ALT.The HBsAg level standing for HBsAg still nends be further validated
-
Key words:
- hepatitis B virus /
- hepatitis B surface antigen /
- hepatitis B e antigen /
- real time PCR
-
[1] Chen CH,Chiu YC,Lu SN,et al.Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues[J].World J Gastroenterol,2014,20(24):7686-7695. [2] Trepo C,Chan HL,Lok A.Hepatitis B virus infection[J].Lancet,2014,384(9959):2053-2063. [3] 乔伟振,李另另,谢平,等.非霍奇金淋巴瘤患者HBV感染状况及HBV DNA载量分析[J].重庆医学,2013,42(4):420-422. [4] Martinot-Peignoux M,Lapalus M,Asselah T,et al.HBsAg quantification:useful for monitoring natural history and treatment outcome[J].Liver Int,2014,34(Suppl 1):97-107. [5] Ning Q,Han M,Sun Y,et al.Switching from entecavir to PegIFN α-2a in patients with HBeAg-positive chronic hepatitis B:a randomised open-label trial(OSST trial)[J].J Hepatol,2014,61(4):777-784. [6] 裴彦祯, 韩涛,马晓艳,等.HBsAg及HBV DNA定量水平在慢性乙型肝炎、肝硬化和肝癌患者中的变化[J].中华肝脏病杂志,2011,19(10):743-746. [7] Thompson AJ,Nguyen T,Iser D,et al.Serum hepatitis B surface antigen and hepatitis B e antigen titers:disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers[J].Hepatology,2010,51(6):1933-1944. [8] 成军,孙长贵,陈瑜,等.低浓度HBsAg人群HBV DNA与HBV M定量结果的关系及评价[J].细胞与分子免疫学杂志,2009,25(7):631-636. [9] Li M,Xi H,Wang Q,et al.Kinetics of serum HBsAg in Chinese patients with chronic HBV infection with long-term adefovir dipivoxil treatment[J].Chin Med J(Engl),2014,127(11):2101-2104. [10] Alghamdi A,Aref N,El-Hazmi M,et al.Correlation between hepatitis B surface antigen titers and HBV DNA levels[J].Saudi J Gastroenterol,2013,19(6):252-257. [11] Wiegand J,Wedemeyer H,Finger A,et al.A decline in hepatitis B virus surface antigen(hbsag) predicts clearance,but does not correlate with quantitative hbeag or HBV DNA levels[J].Antivir Ther,2008,13(4):547-554. [12] Ozdil B,Cosar AM,Akkiz H,et al.Negative correlation between viral load and HBsAg levels in chronic HBV-infected patients[J].Arch Virol,2009,154(9):1451-1455. [13] 郭龙华,陈茶,万泽民,等.乙型肝炎病毒基因组1896位点变异株与野生株的定性检测[J].重庆医学,2013,42(3):308-309. -

计量
- 文章访问数: 1944
- HTML全文浏览量: 256
- PDF下载量: 375
- 被引次数: 0